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Abstract
The qualified presumption of safety (QPS) approach was developed to provide a regularly updated
generic pre-evaluation of the safety of biological agents, intended for addition to food or feed, to
support the work of EFSA’s Scientific Panels. It is based on an assessment of published data for each
agent, with respect to its taxonomic identity, the body of knowledge, safety concerns and antimicrobial
resistance. Safety concerns identified for a taxonomic unit (TU) are, where possible, confirmed at
strain or product level, and reflected by ‘qualifications’. In the period covered by this statement, no
new information was found that would change the status of previously recommended QPS TUs. Of the
36 microorganisms notified to EFSA between April and September 2020, 33 were excluded; seven
filamentous fungi (including Aureobasidium pullulans based on recent taxonomic insights), one
Clostridium butyricum, one Enterococcus faecium, three Escherichia coli, one Streptomyces spp. and
20 TUs that had been previously evaluated. Three TUs were evaluated; Methylorubrum extorquens and
Mycobacterium aurum for the first time and Bacillus circulans was re-assessed because an update was
requested in relation to a new mandate. M. extorquens and M. aurum are not recommended for QPS
status due to the lack of a body of knowledge in relation to use in the food or feed chain and M.
aurum, due to uncertainty concerning its pathogenicity potential. B. circulans was recommended for
QPS status with the qualifications for ‘production purposes only’ and ‘absence of cytotoxic activity’.
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Summary
The European Food Safety Authority (EFSA) asked the Panel on Biological Hazards (BIOHAZ) to
deliver a Scientific Opinion on the maintenance of the qualified presumption of safety (QPS) list. The
QPS list contains biological agents, intentionally added to food and feed, having the QPS status. The
request included three specific tasks as mentioned in the Terms of Reference (ToR).
The QPS process was developed to provide a harmonised generic pre-evaluation procedure to
support safety risk assessments of biological agents performed by EFSA’s scientific Panels and Units.
This process assesses the taxonomic identity, body of knowledge and safety of biological agents.
Safety concerns identified for a taxonomic unit (TU) are, where possible, confirmed at strain or
product level, reflected as ‘qualifications’ that should be assessed at the strain level by EFSA’s Scientific
Panels. A generic qualification for all QPS bacterial TUs applies in relation to the absence of acquired
genes conferring resistance to clinically relevant antimicrobials (EFSA, 2008).
The list of microorganisms is maintained and re-evaluated approximately every 6 months in a
Panel Statement. The Panel Statement also includes the evaluation of microbiological agents newly
notified to EFSA within the previous 6-month period.
The first ToR requires ongoing updates of the list of biological agents notified to EFSA, in the
context of a technical dossier for safety assessment. The overall list (https://doi.org/10.5281/zenodo.
4498901) was updated with the notifications received since the latest review in March 2020. Within
this period, 36 notifications were received by EFSA, of which 22 were proposed for evaluation in Feed,
4 for use as Food Enzymes, Food Additives and Flavourings, 7 as Novel Foods, 2 as Plant Protection
Products and 1 as a Genetically Modified Organism. The new notifications received between April and
September 2020 are included in the current Statement (see Appendix F).
The second ToR concerns the revision of the TUs previously recommended for the QPS list and their
qualifications. For this revision, articles published from January until June 2020 (for protists/algae from
January 2019 to June 2020) were assessed. The articles were retrieved and assessed through an
extensive literature search (ELS) protocol available in Appendix B (see https://doi.org/10.5281/zenodo.
4428668) and the search strategies in Appendix C (see https://doi.org/10.5281/zenodo.4428691). No
new information was found that would affect the QPS status of those TUs or their qualifications.
The third ToR requires a (re)assessment of new TUs notified to EFSA, for their suitability for inclusion
in the updated QPS list at the Knowledge Junction in Zenodo (https://doi.org/10.5281/zenodo.4428353,
Appendix E). The current Statement focuses on the assessments of the TUs that were notified to EFSA
between April and September 2020.
Three of the 36 notifications received, corresponding to three TUs, were evaluated for possible QPS
status; two of these (Methylorubrum extorquens (previously known and notified as Methylobacterium
extorquens) and Mycobacterium aurum) for the first time. Bacillus circulans was re-assessed because
an update was requested in relation to the current mandate.
• Methylorubrum extorquens is not recommended for the QPS status due to a lack of body of
knowledge in relation to its use in the food or feed chain;
• Mycobacterium aurum is not recommended for the QPS list due to a lack of body of knowledge
and uncertainty concerning its pathogenicity potential;
• Bacillus circulans is recommended for the QPS status with the qualifications for ‘production
purposes only’ and ‘absence of cytotoxic activity’.
The remaining 33 notifications were excluded from QPS evaluation for the following reasons: 13
notifications were related to microorganisms that are generally excluded from QPS evaluation (seven
were notifications of filamentous fungi (including Aureobasidium pullulans); one of Clostridium
butyricum, one of Enterococcus faecium, three of Escherichia coli, one of Streptomyces spp.) and 20
were related to TUs that already had QPS status and did not require further evaluation.
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1. Introduction
The qualified presumption of safety (QPS) approach was developed by the EFSA Scientific
Committee to provide a generic concept for risk assessment within the European Food Safety Authority
(EFSA) for microorganisms intentionally introduced into the food chain, in support of the respective
Scientific Panels and Units in the frame of market authorisations, requiring an EFSA safety assessment
(EFSA, 2007). The list, first established in 2007, has been continuously revised and updated. A
Panel Statement is published approximately every 6 months. These Panel Statements include the
results of the assessment of relevant new papers related to the TUs with QPS status. They also contain
the assessment of newly arrived TUs to the EFSA Units on Feed, Food Ingredients and Packaging
(FIP), Nutrition, Pesticides and Genetically Modified Organisms (GMO). After 3 years, a QPS opinion is
published summarising the results of the Panel Statements published in that period.
1.1. Background and Terms of Reference as provided by EFSA
A wide variety of microorganisms are intentionally added at different stages of the food and feed
chain. In the context of applications for market authorisation of these biological agents used, either
directly or as sources of food and feed additives, food enzymes and plant protection products, EFSA is
requested to assess their safety.
EFSA’s work on QPS activities started in 2004 when the Scientific Committee issued a scientific opinion
in continuation of the 2003 working document “On a generic approach to the safety assessment of
microorganisms used in feed/food and feed/food production” prepared by a working group consisting of
members of the former Scientific Committee on Animal Nutrition, the Scientific Committee on Food and
the Scientific Committee on Plants of the European Commission.1 The document, made available for
public consultation, proposed the introduction of the concept of Qualified Presumption of Safety (QPS),
to be applied to selected groups of microorganisms. Microorganisms not considered suitable for QPS
status would remain subject to a full safety assessment. EFSA management asked its Scientific
Committee to consider whether the QPS approach could be applied to the safety assessment of
microorganisms across the various EFSA Scientific Panels. In doing so, the Committee was required to
take into account the response of the stakeholders to the QPS approach. In its 2005 opinion (EFSA,
2005), the Scientific Committee concluded that the QPS approach could provide a generic assessment
system that could be applied to all requests received by EFSA for the safety assessments of
microorganisms deliberately introduced into the food and feed chain. Its introduction was intended to
improve transparency and ensure consistency in the approach used across the EFSA Panels. Applications
involving a taxonomic unit belonging to a species that falls within a QPS group do not require a full safety
assessment.
Several taxonomic units (usually species for bacteria and yeasts; families for viruses) have been
included in the QPS list, either following notifications to EFSA, or proposals made initially by
stakeholders during a public consultation in 2005, even if they were not yet notified to EFSA (EFSA,
2005). The EFSA Scientific Committee reviewed the range and numbers of microorganisms likely to be
the subject of an EFSA Opinion and, in 2007, published a list of microorganisms recommended for the
QPS list.
In their 2007 opinion (EFSA, 2007), the Scientific Committee recommended that a QPS approach
should provide a generic concept to prioritise and to harmonise safety risk assessment of
microorganisms intentionally introduced into the food chain, in support of the respective Scientific
Panels and EFSA Units in the frame of the market authorisations. The same Committee recognised that
there would have to be continuing provision for reviewing and modifying the QPS list and in line with
this recommendation, the EFSA Panel on Biological Hazards (BIOHAZ) took the prime responsibility for
this and started reviewing annually the existing QPS list. In 2008, the first annual QPS update was
published (EFSA, 2008).
In 2014, the BIOHAZ Panel, in consultation with the Scientific Committee, decided to change the
revision procedure; the overall assessment of the taxonomic units previously recommended for the
QPS list (EFSA BIOHAZ Panel, 2013) was no longer carried out annually but over a 3-year period. From
2017, the search and revision of the possible safety concerns linked to those taxonomic units started
instead to be carried out every 6 months through extensive literature searches (ELS). The update of
the 2013 QPS list (EFSA BIOHAZ Panel, 2013) was done in 2016 (EFSA BIOHAZ Panel, 2017). From
2016 on, the QPS list (https://zenodo.org/record/1146566) and the list of notifications to EFSA
1 https://ec.europa.eu/food/sites/food/files/safety/docs/sci-com_scf_out178_en.pdf
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(https://zenodo.org/record/3607183) are constantly updated, independent of the QPS opinion and
available at the Knowledge Junction in Zenodo. The most recent QPS opinion (EFSA BIOHAZ Panel,
2020a) summarises the main results of the 3-year ELS on the QPS TUs, together with an update of the
process for granting QPS Status. In the meantime, every 6 months a Panel Statement, compiling the
assessments for a QPS status of the microbiological agents notified to EFSA requested by the Feed
Unit, the Food Ingredients and Packaging (FIP) Unit, the Nutrition Unit, the Pesticides Unit and the
Genetically Modified Organisms (GMO) Unit, as well as the summary of each 6-month ELS exercise,
has been produced and published. Each QPS Panel Statement contains the evaluations of the new
notifications for microorganisms submitted for possible QPS status. It also contains the result of an
Extensive Literature Search (ELS) performed every 6 months concerning possible new safety concerns
related to the TUs already included in the QPS list. The data identified are used to decide whether any
TU may or may not remain on the QPS list, and whether any qualifications need to be revised.
Establishing a QPS status is based on four pillars: [1] the taxonomic grouping for which QPS is
sought (‘taxonomic identification’); [2] whether sufficient information is available about the proposed
group of organisms to conclude on human/animal exposure by food/feed (‘body of knowledge’); [3]
whether the grouping proposed contains known pathogens (‘safety’) and, finally, [4] the intended end
use (‘intended use’). If a hazard related to a TU is identified, which can be tested at the strain or
product level, a ‘qualification’ to exclude that hazard may be established. The subject of these
qualifications for the microbial strain under investigation is evaluated by the EFSA Unit to which the
application dossier has been allocated. Absence of acquired genes coding for resistance to
antimicrobials relevant for humans and animals is a generic qualification for all bacterial TUs; the
absence of antimycotic resistance should be proved if the yeasts are to be used as viable organisms in
the food or feed chains. The qualification ‘for production purpose only’ implies the absence of viable
cells of the production organism in the final product and can also be applied to food and feed products
based on microbial biomass (EFSA BIOHAZ Panel, 2020a).
Because the QPS evaluation is, after its initial creation, only triggered through an application dossier
notified to EFSA, the QPS list is not exhaustive.
In summary, the QPS provides a generic safety pre-assessment approach for use within EFSA that
covers safety concerns for humans, animals and the environment. In the QPS concept, a safety
assessment of a defined taxonomic unit is performed independently of the legal framework under
which the application is made in the course of an authorisation process. Although general human
safety is part of the evaluation, specific issues connected to type and level of exposure of users
handling the product (e.g. dermal contact, inhalation, ingestion) are not addressed. In the case of
Genetically Modified Microorganisms (GMM) for which the species of the recipient strain qualifies for
the QPS status, and for which the genetically modified state does not give rise to safety concerns, the
QPS approach can be extended to genetically modified production strains (EFSA BIOHAZ Panel, 2018).
The assessment of potential allergenic microbial residual components is beyond the QPS remit;
however, if there is science-based evidence for microbial species it is reported. These aspects are
separately assessed, where applicable, by the EFSA Panel responsible for assessing the application.
The lowest TU for which the QPS status is granted is the species level for bacteria, yeasts and
protists/algae, and family for viruses.
Filamentous fungi, bacteriophages, Streptomycetes, Oomycetes, Enterococcus faecium, Escherichia
coli and recently also Clostridium butyricum (EFSA BIOHAZ Panel, 2020b) are excluded from the QPS
assessments based on an ambiguous taxonomic position or the possession of potentially harmful traits.
The Terms of Reference are as follows:
ToR 1: Keep updated the list of biological agents being notified in the context of a technical dossier
to EFSA Units such as Feed, Pesticides, Food Ingredients and Packaging (FIP) and Nutrition, for
intentional use directly or as sources of food and feed additives, food enzymes and plant protection
products for safety assessment.
ToR 2: Review taxonomic units previously recommended for the QPS list and their qualifications
when new information has become available. The latter is based on a review of the updated literature
aiming at verifying if any new safety concern has arisen that could require the removal of a taxonomic
unit from the list, and to verify if the qualifications still efficiently exclude safety concerns.
ToR 3: (Re) assess the suitability of new taxonomic units notified to EFSA for their inclusion in the
QPS list. These microbiological agents are notified to EFSA and requested by the Feed Unit, the FIP
Unit, the Nutrition Unit or by the Pesticides Unit.
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2. Data and methodologies
2.1. Data
In reply to ToR 3, (re)assessment of the suitability of TUs notified within the time period covered by
this Statement (from April to September 2020) is carried out. The literature review considered the
identification, the body of knowledge, the potential safety concerns and the knowledge on acquired
antimicrobial resistance (AMR). Relevant databases, such as PubMed, Web of Science, CAB Abstracts
or Food Science Technology Abstracts (FSTA) and Scopus, were searched. More details on the search
strategy, search keys and approach are described in Appendix A.
Only valid TUs covered by the relevant international committees on the nomenclature for
microorganisms are considered for the QPS assessment.
2.2. Methodologies
2.2.1. Evaluation of a QPS recommendation for taxonomic units notified to EFSA
In response to ToR 1, the EFSA Units were asked to update the list of biological agents being
notified to EFSA. A total of 36 notifications were received between March and September 2020, of
which 22 were for evaluation in Feed, four for use as Food Enzymes, Food Additives and Flavourings,
seven as Novel Foods, two as Plant Protection Products and 1 as a Genetically Modified Organism
(Table 1). Aureobasidium pullulans was notified twice, once as a yeast and once as a filamentous
fungus, but only counted as one TU (filamentous fungus).
In response to ToR 3, three of the 36 notifications, corresponding to three TUs, were evaluated for
possible QPS status, two of these for the first time, i.e. Methylorubrum extorquens (previously known
and notified as Methylobacterium extorquens) and Mycobacterium aurum. The third, Bacillus circulans,
was re-assessed because an update was requested in the current mandate. The remaining 33
notifications were excluded from QPS evaluation for the following reasons: 13 notifications were
related to microorganisms that are generally excluded from QPS evaluation (seven were notifications of
filamentous fungi (including Aureobasidium pullulans); one of Clostridium butyricum, one of
Enterococcus faecium, three of Escherichia coli, one of Streptomyces spp.), and 20 were related to
TUs that already have QPS status and do not require further evaluation in this mandate.
Table 1: Notifications received by EFSA, per risk assessment area and by biological group, from
April to September 2020
Risk assessment area
Not evaluated in this








Feed 15 7 0 22
Bacteria 11 6 0 17
Filamentous fungi 0 1 0 1
Yeasts 4 0 0 4
Novel foods 2 3 2 7
Bacteria 1 0 2 3
Filamentous fungi 0 3 0 3
Protists/Algae 0 0 0 0
Yeasts 1 0 0 1
Plant protection products 0 2 0 2
Bacteria 0 0 0 0
Filamentous fungi 0 2 0 2
Viruses 0 0 0 0
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2.2.2. Monitoring of new safety concerns related to species with QPS status
In reply to ToR 2, concerning the revision of the TUs previously recommended for the QPS list and
their qualifications, an extensive literature search (ELS) was conducted as described in Appendix B –
ELS protocol, see https://doi.org/10.5281/zenodo.4428668, and in Appendix C Search strategies – see
https://doi.org/10.5281/zenodo.4428691, respectively.
The Artificial Intelligence (AI) function was used for pre-screening of papers for Bifidobacterium
spp., Carnobacterium divergens, lactobacilli, Lactococcus lactis, bacilli and yeasts, followed by a second
screening of those articles retrieved by AI which was carried out by two experts.
The aim of the ELS was to identify any publicly available studies reporting on safety concerns for
humans, animals or the environment, caused by QPS organisms since the previous QPS review (i.e.
publications from January to June 2020), and for protists/algae from January 2019 to June 2020.
For case reports of human infections or intoxications, important additional information includes
whether any negative impacts are confined to affected persons with conditions favouring opportunistic
infections, e.g. immunosuppression, and whether transmission occurred through food or other routes,
when described (e.g. medical devices). Studies indicating the presence of virulence factors (e.g. toxins
and enzymes that may contribute to the pathogenicity of the microorganism) in the TU are also
reported as relevant when identifying potential safety concerns.
Several of the QPS-TUs are sporadically reported as causing infections in individuals with recognised
predisposing conditions for the acquisition of opportunistic infections e.g. cardiovascular conditions
favouring endocarditis, people in the extreme lower or upper age spectrum, or with other conditions
which can lead to impairment of the immunological system, such as patients subjected to transplants,
undergoing cancer therapy, suffering from physical trauma or tissue damage or HIV patients.
Moreover, gastrointestinal tract-related conditions with mucosal impairment can also be a predisposing
factor for infection. Previous use of the microorganisms being assessed as food supplements for
humans was reported in many of these cases. A living microorganism used as a food supplement does
not fall under the remit of the QPS assessment. Nevertheless, the QPS assessment takes into
consideration these reports, extracting relevant information whenever justified. For a detailed protocol
of the process and search strategies, refer to Appendices B and C.
After removal of duplicates, 1,723 records were submitted to the title screening step, which led to
the exclusion of 1,609 of them. The remaining 114 records were found eligible for the title and
abstract screening step, which led to the exclusion of 57 of these. Of the 57 articles that finally
reached the article evaluation step (full text), 21 were considered to report a potential safety concern
and were further analysed.
The flow of records from their identification by the different search strategies (as reported in
Appendix C) to their consideration as potentially relevant papers for QPS is shown in Table 2.
Risk assessment area
Not evaluated in this








Food enzymes, food additives and
flavourings
3 1 0 4
Bacteria 1 0 0 1
Filamentous fungi 0 1 0 1
Yeasts 2 0 0 2
Genetically modified organism 0 0 1 1
Bacteria 0 0 1 1
Total 20 13 3 36
QPS: qualified presumption of safety.
(a): The number includes seven notifications of filamentous fungi, one of Clostridium butyricum (bacterium), one of
Enterococcus faecium (bacterium), three of Escherichia coli (bacterium) and one of Streptomyces spp. (bacterium), all
excluded from QPS evaluation.
(b): Three notifications corresponding to three TUs, one was last evaluated in 2017 (Bacillus circulans) and two were evaluated
for the first time (Methylorubrum extorquens (previously known and notified as Methylobacterium extorquens),
Mycobacterium aurum).
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3. Assessment
The search strategy (key words, literature databases, number of papers found) followed for the
assessment of the suitability of TUs notified to EFSA for their inclusion in the updated QPS list (reply to
ToR 3) can be found in Appendix A.
3.1. Taxonomic units evaluated during the previous QPS mandate and




Bacillus circulans is a valid species name with standing in nomenclature (Skerman et al., 1980),
belonging to the genus Bacillus. It is a facultative anaerobe, motile, Gram-positive, endospore forming,
rod shaped bacterium.
Body of knowledge
The vast majority of publications concerned enzymes for production or modification of
polysaccharides that could be used in foods, such as glycosidase, galactosidase, mannase and
chitinase (Walia et al., 2017; Tanaka et al., 2018, Itoh and Kimoto, 2019; Yano et al., 2019). One
















Number of articles retrieved
Bacteria (total) 1,099 54 25 11
Bacilli(a) 332 18 9 3
Bifidobacterium(a) 69 7 4 1
Carnobacterium divergens(a) 11 0 0 0
Corynebacterium glutamicum 23 1 0 0
Gluconobacter oxydans/
Xanthomonas campestris
144 1 0 0
Lactobacilli(a) 179 17 6 5
Lactococcus lactis(a) 18 3 3 2
Leuconostoc 53 4 2 0
Microbacterium imperiale 0 0 0
Oenococcus 34 1 0 0
Pasteuria nishizawae 0
Pediococci 164 1 1 0
Propionibacterium 22 0 0 0
Streptococcus thermophilus 50 1 0 0
Viruses (total) 67 2 0 0
Alphaflexiviridae/Potyviridae 24 2 0 0
Baculoviridae 43 0 0 0
Yeasts(a) 355 52 27 10
Protists/Algae 202 6 5 0
Total 1,723 114 57 21
Excluded 1,609 57 36
(a): Number of references prescreened by AI: Bifidobacterium spp. (199)/Carnobacterium divergens (133); lactobacilli (387);
Lactococcus lactis (128), bacilli (407), yeasts (660).
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publication reported the use of B. circulans strains as a probiotic in fish (Singh et al., 2019) and two
articles report the use of its spores to control gastrointestinal nematodes in sheep and cattle (Sinott
et al., 2016; Pinto et al., 2017).
Safety concerns
Alebouyeh et al. (2011) reported a case of fatal sepsis caused by a B. circulans strain in an
immunocompromised man with a history of urinary tract infections. Sanyal et al. (2015) described a
non-diabetic foot infection in a 60-year-old malnourished man caused by a haemolytic-positive B.
circulans strain. The taxonomical identification of the isolates in both papers was made using
phenotypic tests and the analysis of the 16S rRNA gene sequence.
Conclusion on a recommendation for the QPS list
B. circulans has been widely studied as an enzyme producer with potential application for food
additives and is recommended for the QPS list with the qualifications ‘for production purposes only’
and ‘absence of cytotoxic activity’.
3.1.2. Yeasts
Aureobasidium pullulans
Aureobasidium pullulans was evaluated for QPS (as a yeast) in 2009 and considered not suitable for
inclusion in the QPS list. This species is excluded from further QPS assessment based on recent
taxonomic insights (see further details in Section 3.4).




Methylorubrum extorquens is a TU with standing in nomenclature. It has been described by Green
and Ardley (2018) as a novel species name for Methylobacterium extorquens, described by Bousfield
and Green (1985) and Kato et al. (2005). Strains belonging to the Methylorubrum genus have a Gram-
negative cell wall and grow as deep pink/red orange colonies (due to the pigment oxo-carotenoid) on
media with methanol as the sole carbon and energy source. The G+C content of the DNA is 65.8–71.8
mol%. The genus Methylorubrum shares many common features with the genus Methylobacterium.
Body of knowledge
M. extorquens is isolated from environmental sources (soil, water etc.) can produce a variety of
value-added products from methanol and is a well-studied microorganism for biotechnological
applications but with limited information on its use in the food and feed chain (reviewed by Ochsner
et al., 2015). The studies reviewed reported the production of bulk chemicals such as
polyhydroxyalkanoates and amino acids, fine chemicals such as acids derived from the ethylmalonyl-
CoA pathway and proteins as single cell proteins (biomass), insecticides, bacteriocins and green
fluorescent protein.
Safety concerns
Case reports of infections with M. extorquens were reported in immunocompromised patients (Kaye
et al., 1992; Engler and Norton, 2001; Kovaleva et al., 2014). Nosocomial infections are favoured by its
ability to form biofilms and colonise medical devices (Kovaleva et al., 2014).
Antimicrobial resistance aspects
M. extorquens strains are reported to be intrinsically resistant to quinolones (Kim et al., 2005).
Conclusion on a recommendation for the QPS list
M. extorquens is not recommended for QPS status due to a lack of body of knowledge in relation to
its use in the food or feed chains.
BIOHAZ statement on QPS: suitability of taxonomic units notified until September 2020
www.efsa.europa.eu/efsajournal 10 EFSA Journal 2021;19(1):6377
Mycobacterium aurum
Identity
Mycobacterium aurum is a taxonomic name with standing in nomenclature (Nouioui et al., 2018),
within the order Actinomycetales, suborder Corynebacterineae and family Mycobacteriaceae. The
species has the valid synonym Mycolicibacterium aurum (Gupta et al., 2018).
Body of knowledge
The information available mainly deals with the use of this species as a non-infectious surrogate
model for Mycobacterium tuberculosis. Limited information is available on ecological aspects of this
species and no data on the presence of this organism in the food chain is available. Due to its
relatedness to Mycobacterium tuberculosis and its more rapid growth, this species has been used for
screening the effects of new anti-tuberculosis compounds.
Safety concerns
The species has been associated with infections in immunocompromised patients (Esteban et al.,
1998; Koranyi and Ranalli, 2003; Martın-Aspas et al., 2008) and with keratitis (Honarvar et al., 2012) in
reports using bacterial identification methods currently recognised to be prone to misidentifications of
Mycobacterium species (Tortoli, 2014). No food-borne origin could be established.
Conclusion on a recommendation for the QPS list
Mycobacterium aurum cannot be recommended for the QPS list due to a lack of body of knowledge
and uncertainty with regard to its pathogenicity potential.
3.3. Monitoring of new safety concerns related to organisms on the QPS
list
The summaries of the evaluation of the possible safety concerns for humans, animals or the
environment described and published since the previous ELS exercise (i.e. articles published between
January and June 2020, and for protists/algae from January 2019 to June 2020) as described in
Appendices B and C with reference to the articles selected as potentially relevant for the QPS exercise
(Appendix D) for each of the TUs or groups of TUs that are part of the QPS list (Appendix E), are
presented below.
3.3.1. Gram-positive non-sporulating bacteria
Bifidobacterium spp.
A search for papers potentially relevant for Bifidobacterium spp. provided 199 references. The AI
analysis left 69. Title screening left seven references for abstract inspection, then four for a full article
appraisal. This last step identified one article (Sirichoat et al., 2020) that might deal with safety
concerns but the article was not considered relevant because it described the antimicrobial resistance
of Bifidobacterium among other lactic acid bacteria from human vagina, a feature covered by the
general qualification for bacteria ‘absence of antimicrobial activity’.
Based on the available evidence, the QPS status of Bifidobacterium spp. is not changed.
Carnobacterium divergens
A search for papers potentially relevant for Carnobacterium divergens provided 14 references. The
AI analysis left 11. No article was considered relevant at the level of title screening for this TU.
Consequently, the QPS status of C. divergens is not changed.
Corynebacterium glutamicum
A search for papers potentially relevant to the QPS evaluation of Corynebacterium glutamicum
provided 23 references. One paper reached the level of title and abstract screening but did not reach
full text evaluation. Therefore, no new safety concerns were identified and the QPS status of
C. glutamicum is not changed.
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Lactobacilli
The genus Lactobacillus was recently subdivided into 25 genera (Zheng et al., 2020); the 37 species
which have QPS status granted have been allocated to 13 of these genera. The search for papers that
might raise safety concerns was done using both the previous and the new names and provided a total of
566 references. The AI analysis left 179 articles. Title screening of these provided 17 references for
abstract inspection, which further reduced their number to 5 describing a possible safety concern. Full
paper review identified three with reliable microorganism identification procedures. All three dealt with
Lacticaseibacillus rhamnosus infections. Two of the papers described bacteraemia cases (Chiang et al.,
2020; Sendil et al., 2020) while the third was on endocarditis (Campagne et al., 2020). In all three cases,
predisposing conditions for opportunistic infections were recorded. Chiang et al. (2020) described the
case of an extremely premature girl (born through Caesarean section at 26 weeks of pregnancy), who
had a central catheter inserted and was administered L. rhamnosus GG (5 9 108 cfu/day) for necrotising
enterocolitis prevention (the blood cultures recovered a strain identical to the probiotic). Sendil et al.
(2020) described bacteraemia in a 75-year-old man who had received a renal transplant several years
before which was showing signs of rejection despite extensive immunosuppressive therapy. Associated
comorbidities included type 2 diabetes, hypertension, stroke and coronary insufficiency. Finally,
Campagne et al. (2020) described endocarditis in a middle-aged man who suffered previous interatrial
communication surgery and presented with extensive dental caries.
Based on the available evidence as described above, the QPS status of the species previously
included within the genus Lactobacillus spp. and now belonging to any of the derived genera is not
changed.
Lactococcus lactis
A search for papers potentially relevant for the QPS status of Lactococcus lactis, provided 146
references. The AI analysis left 18 papers. Title and abstract screenings of these reduced their number
to 2, describing a possible safety concern. Both were excluded because the identification procedures
were not considered to be reliable.
Based on the available evidence as described above, the QPS status of Lactococcus lactis is not
changed.
Leuconostoc spp.
A search for papers potentially relevant for the QPS evaluation of QPS Leuconostoc species
provided 53 references. The analysis of their titles left four articles for title/abstract screening. Two
articles reached full text evaluation, but neither dealt with safety concerns. Consequently, the QPS
status of Leuconostoc spp. is not changed.
Microbacterium imperiale
A search for papers potentially relevant for the QPS evaluation of QPS Microbacterium imperiale
provided no reference. Consequently, the QPS status of M. imperiale is not changed.
Oenococcus oeni
A search for papers potentially relevant for the QPS evaluation of Oenococcus oeni provided 34
references. The analysis of their titles left one article for title/abstract screening. This article was not
considered further. Consequently, the QPS status of O. oeni is not changed.
Pediococcus spp.
A search for papers potentially relevant for the QPS evaluation of Pediococcus spp. provided
164 references. The analysis of their title/abstracts left one article for the evaluation phase, but it did
not refer to safety concerns. No article reached the full text evaluation stage. Consequently, the QPS
status of Pediococcus spp. is not changed.
Propionibacterium
A search for papers potentially relevant for the QPS evaluation of Propionibacterium spp. provided
22 references. Following the analysis of their titles, no articles were selected for title/abstract screening
or the full article evaluation phase; thus, no new safety concerns were identified. Consequently, the
QPS status of Propionibacterium spp. is not changed.
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Streptococcus thermophilus
A search for papers potentially relevant for the QPS evaluation of Streptococcus thermophilus
provided 50 references. The analysis of their titles left one article for title and abstract screening that
did not deal with safety concerns. Therefore, no article reached the evaluation phase, and the QPS
status of S. thermophilus is not changed.
3.3.2. Gram-positive spore-forming bacteria
Bacilli
A search for papers potentially relevant for bacilli provided 739 references. The AI analysis left 332
articles. The analysis of their titles by two experts left 18 articles for the title/abstracts phase and,
from these, nine articles passed to the full text phase for further analysis. Six papers did not deal with
safety concerns. The paper of Bog et al. (2020) described the results of an in vitro pathogenicity test
of a B. licheniformis strain. The paper had methodological problems in relation to strain identification
and used an unvalidated in vitro pathogenicity test with very high bacterial cell density. The paper of
Farhan et al. (2020) reported the isolation of a B. subtilis strain in relation to mastitis. The paper had
methodological problems in relation to strain identification and did not document source attribution.
The paper of Mohkam et al. (2020) had methodological concerns in relation to weak and not
reproducible PCR results. Weak haemolysis and cytotoxic effect of a B. subtilis strain were reported, a
possible concern which is covered by the QPS qualification for bacilli of ‘not showing cytotoxic activity’.
The ELS did not identify any information that would change the status of bacilli included in the QPS
list and confirmed the qualification ‘absence of cytotoxicity’.
Geobacillus stearothermophilus
A search for papers potentially relevant for Geobacillus stearothermophilus provided 407 references.
The AI analysis left 332 articles. The analysis of their titles by two experts left 18 articles and for 9 of
these the full text was analysed. None dealt with this species. Consequently, the QPS status G.
stearothermophilus is not changed.
Pasteuria nishizawae
A search for papers potentially relevant for the QPS evaluation of Pasteuria nishizawae provided 0
references. Consequently, the QPS status of P. nishizawae is not changed.
3.3.3. Gram-negative bacteria
Gluconobacter oxydans
A search for papers potentially relevant to the QPS evaluation of Gluconobacter oxidans and
Xanthomonas campestris provided 144 references.
The analysis of their titles left one article, which was excluded following the title and abstract
screening. No paper reached the final selection phase for this TU. Consequently, the QPS status of G.
oxydans is not changed.
Xanthomonas campestris
As previously mentioned, the search for papers potentially relevant for the QPS evaluation of
Gluconobacter oxidans and Xanthomonas campestris provided 144 references. The analysis of their
titles left one article, which was excluded following the title and abstract screening. No paper reached
the evaluation phase for this TU. Consequently, the QPS status of X. campestris is not changed.
3.3.4. Yeasts
The ELS searches for potentially relevant studies on the yeasts with QPS status provided 1,015
references. The AI analysis left 355 articles. After title screening by two experts, 52 studies remained
for the title/abstract phase, and from these 27 articles passed to the full article appraisal. Out of these,
14 were relevant for the QPS evaluation, of which 10 reported a possible safety concern.
Four studies did not directly report safety concerns. Two looked at potential factors for virulence in
yeasts (Alves et al., 2020; Chakraborty et al., 2020), but not at relationships between these factors
and actual virulence. Zhai et al. (2020) included the QPS species D. hansenii, K. marxianus and
Y. lipolytica when calculating the relative abundance of potentially pathogenic fungi from
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gastro-intestinal metagenomics data but reported no information on whether these species contributed
to infections. Stavrou et al. (2020) reported new data on minimum inhibitory concentrations of
antifungal drugs for opportunistic yeasts, among them the QPS species D. hansenii, K. marxianus,
W. anomalus and Y. lipolytica. These data can be used for testing the qualification ‘absence of
antimycotic resistance’ of QPS yeast species used as viable cells.
Ten studies discussed potentially relevant safety concerns for QPS yeast species, which are
discussed below.
For the species Candida cylindracea, Hanseniaspora uvarum, Kluyveromyces lactis,
Komagataella pastoris, Komagataella phaffi, Cyberlindnera jadinii, Ogataea angusta,
Saccharomyces bayanus, Saccharomyces pastorianus, Schizosaccharomyces pombe,
Xanthophyllomyces dendrorhous, Yarrowia lipolytica and Zygosaccharomyces rouxii, no
safety concerns were reported. Consequently, the QPS status does not change for these species.
Debaryomyces hansenii
The anamorph name of D. hansenii is Candida famata.
Esteves et al. (2020) obtained 75 yeast isolates from the oral cavity of patients diagnosed with
eating disorders at a clinic in Sao Paulo, Brazil. Out of the isolates, 43 were identified by conventional
mycological methods and MALDI-TOF. Two were identified as C. famata. The source attribution in the
paper was not documented and the identification by MALDI-TOF was not further confirmed by
molecular methodology.
In conclusion, the literature update did not identify any information that would change the QPS
status of D. hansenii.
Kluyveromyces marxianus
The anamorph name of K. marxianus is Candida kefyr.
Aboualigalehdari et al. (2020) characterised yeast isolates from the oropharyngeal tract of 201 HIV-
infected patients in Iran. Out of the 127 isolates obtained from 88 of the patients, three were
identified as K. marxianus. It is not clear, however, whether the patients had been diagnosed with
candidiasis. In another study (Kord et al., 2020), a total of 137 yeast blood isolates from 107 patients
in two tertiary care training hospitals in Tehran were retrospectively investigated. The patients had
underlying diseases (pulmonary diseases, solid tumours or diabetes). Two of the strains were identified
as K. marxianus. Mirhendi et al. (2020) obtained a total of 235 yeast strains from various body fluids
of children admitted to a paediatric intensive care unit in a hospital in Iran, having suspected or
documented invasive candidiasis. All children were prematurely born and/or had underlying diseases.
Three of the isolates were identified as K. marxianus. Susceptibility to amphotericin B, fluconazole,
voriconazole, micafungin and anidulafungin was determined. Finally, Pote et al. (2020) reported that
three out of their 176 clinical yeast isolates from hospitals in India were K. marxianus. However, the
study contains no clinical information for the isolates. They compared DNA sequencing of the 28S
rRNA gene with growth on chromogenic media and MALDI-TOF for yeast identifications. Using the
sequencing as reference, MALDI-TOF was able to identify the K. marxianus isolates, whereas growth
on chromogenic media was not.
In conclusion, the literature update mentioned only the isolation of K. marxianus from patients who
are immunocompromised and/or have underlying disease. Also, methodological problems concerning
identification and source attribution were noted. So, the papers did not identify any information that
would change the QPS status of K. marxianus.
Saccharomyces cerevisiae
The anamorph form of S. cerevisiae is not described. A synonym of this species is Saccharomyces
boulardii.
Three references reported safety concerns for humans. Pote et al. (2020) compared three methods
for yeast identifications, growth on chromogenic media, DNA sequencing of the 26S rRNA gene and
protein profiles using MALDI-TOF. The conclusion is that MALDI-TOF is able to identify common
species, but its effectiveness is limited for uncommon species of Candida, or members of uncommon
genera. The preferred methodology is DNA sequencing. The other two papers which described clinical
cases of S. cerevisiae concerned a 4-year-old boy with acute lymphoblastic leukaemia presenting with
hepatosplenic S. cerevisiae infection (Davies et al., 2020) and S. cerevisiae fungaemia in a patient with
Clostridium difficile-associated diarrhoea (Landaburu et al., 2020). The latter emphasised that probiotic
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treatment of patients with serious gastrointestinal disorders has to be carefully considered and
followed up.
These new reports of S. cerevisiae did not add any new information that would change the QPS
status of this species.
Wickerhamomyces anomalus
The anamorph name of W. anomalus is Candida pelliculosa.
Two references related to possible concerns for human safety were identified.
Bhaskaran et al. (2020) characterised 80 clinical strains, from patients with diagnosed Candida
infection, from a tertiary hospital in India. Identification was by traditional growth tests and multiplex
PCR, which is not the usual technique used for yeast identification, and four of the isolates were
reported as W. anomalus. In a clinical case report, infection with W. anomalus was responsible for
fungal arthritis and led to irreversible joint destruction owing to delayed diagnosis and treatment. The
case was not food related; the patient was a 75-year-old woman with a 3-year history of knee
problems and surgery 32 months earlier without antifungal treatment (Song et al., 2020).
The literature update did not identify any information that would change the QPS status of W.
anomalus.
3.3.5. Protists/Algae
ELS was performed for all three species together, as indicated below.
Aurantiochytrium limacinum
Aurantiochytrium limacinum is a member of the Thraustochytriacea and is considered to be a
protist.
A search for papers potentially relevant for the QPS evaluation of protists/algae provided 202
references. Following the analysis of their titles, 6 and of their title/abstracts, 5 articles were selected
for the full article evaluation phase, of which 1 was on a different microorganism and 1 on A.
limacinum. No article identified a possible safety concern. Therefore, the QPS status of A. limacinum is
not changed.
Euglena gracilis
A search for papers potentially relevant for the QPS evaluation of protists/algae provided 202
references. Following the analysis of their titles, 6 and of their title/abstracts, 5 articles were selected
for the full article evaluation phase of which one was on a different microorganism and two were on
Euglena gracilis. No article identified a possible safety concern. Therefore, the QPS status of E. gracilis
is not changed.
Tetraselmis chuii
A search for papers potentially relevant for the QPS evaluation of protists/algae provided 202
references. Following the analysis of their titles, 6 and of their title/abstracts, 5 articles were selected
for the full article evaluation phase of which one was on a different microorganism and one was on
Tetraselmis chuii. No article identified a possible safety concern. Therefore, the QPS status of T. chuii is
not changed.
3.3.6. Viruses used for plant protection
Alphaflexiviridae and Potyviridae
A search for papers potentially relevant for the QPS evaluation of viruses of the Alphaflexiviridae
and Potyviridae provided 24 references. After title screening, two papers reached the title/abstract
screening stage. No paper reached the final selection phase, thus no new safety concern was
identified. Therefore, the current QPS status remains unchanged.
Baculoviridae
A search for papers potentially relevant for the QPS evaluation of Baculoviridae provided 43
references. No article dealing with Baculoviridae passed the title screening, thus no new safety concern
was identified. Therefore, the current QPS status remains unchanged.
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3.4. Distinction between yeasts and filamentous fungi
The distinction between a filamentous fungus and a yeast, and thus whether an organism would be
eligible for QPS evaluation and status (yeast), or not (filamentous fungi) is sometimes not clear-cut.
In their taxonomic study, Kurtzman et al. (2011) define yeasts as follows: ‘In summary, yeasts,
whether ascomycetes or basidiomycetes, are generally characterised by budding or fission as the
primary means of asexual reproduction and have sexual states that are not enclosed in fruiting bodies’.
This definition implies that yeasts are not expected to belong to any other fungal phylum than
ascomycetes and basidiomycetes. However, they consider that of the three lineages within the
Ascomycota, only two contain yeasts, whereas the third (Pezizomycotina) does not.
The decision whether a species should be considered to be a yeast or a filamentous fungus for QPS
purposes is taken on a case-by-case basis, but applying the following general rules and limitations: A
fungus may be subject to evaluation if it i) belongs to the phyla Ascomycota (excluding the
Pezizomycotina) or Basidiomycota and ii) is treated as a yeast by taxonomic literature. As supporting
information, the taxonomy applied by internationally recognised microbial culture collections is
considered (e.g. Fungal Biodiversity Centre (CBS) - Fungi strains; https://wi.knaw.nl/page/fungal_table
with the yeast page https://theyeasts.org/).
Aureobasidium pullulans is a relatively well-studied fungal species since it is of interest within
biotechnology and biological control of plant diseases. It is dimorphic and belongs to the
Pezizomycotina lineage (and the order Dothidiales) of the ascomycetes and is sometimes referred to as
a yeast or as ‘yeast-like’. As documented above, Kurtzman et al. (2011) do not consider the genus
Aureobasidium as yeasts and there is no chapter on the genus in their taxonomy.
In line with the exclusion of Aureobasidium by Kurtzman et al. (2011), a recent review (Naranjo-
Ortiz and Gabaldon, 2019) reported that: ‘The basic body plan of this subphylum (Pezizomycotina) is
filamentous and anastomosed’, and these authors do not refer to any fungi within Pezizomycotina as
‘yeasts’, or ‘yeast-like’ either. They also note that typically, members of Pezizomycotina contain a high
abundance of enzymes for secondary metabolism, which is generally in contrast to yeasts but similar
to filamentous fungi.
Conclusions
ToR 1: Keep updated the list of biological agents being notified, in the context of a
technical dossier to EFSA Units (such as Feed, Food Ingredients and Packaging, Nutrition,
Pesticides, Genetically Modified Microorganisms), for intentional use in feed and/or food
or as sources of food and feed additives, enzymes, plant protection products for safety
assessment:
• Between April and September 2020 (for protists/algae from January 2019 to June 2020), the
QPS list was updated with 36 notifications that were received by EFSA, of which 22 were
proposed for evaluation in Feed, four for use as Food Enzymes, Food Additives and
Flavourings, seven as Novel Foods, two as Plant Protection Products and one as a Genetically
Modified Organism.
ToR 2: Review taxonomic units previously recommended for the QPS list and their
qualifications when new information has become available:
• In relation to the results of the monitoring of possible new safety concerns related to the QPS
list, there were no results to justify removal of any TUs from the QPS list or changes in their
respective qualifications.
ToR 3: (Re)assess the suitability of taxonomic units notified to EFSA not present in the
current QPS list for their inclusion in that list:
• Out of the 36 notifications received, 20 were related to TUs that already had QPS status and
did not require further evaluation.
• Of the remaining 16 notifications, 13 were related to TUs excluded from QPS evaluation: seven
were notifications of filamentous fungi, (including Aureobasidium pullulans based on recent
taxonomic insights); one of Clostridium butyricum, one of Enterococcus faecium, three of
Escherichia coli, one of Streptomyces spp.
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• Three notifications, corresponding to three TUs, were evaluated for possible QPS status, two of
these (Methylorubrum extorquens (previously known as Methylobacterium extorquens) and
Mycobacterium aurum) for the first time. Bacillus circulans was re-assessed because an update
was requested in relation to the current mandate.
 Methylorubrum extorquens is not recommended for QPS status due to a lack of body of
knowledge in relation to its use in the food or feed chain;
 Mycobacterium aurum is not recommended for the QPS list due to lack of body of
knowledge and uncertainty concerning its pathogenicity potential;
 Bacillus circulans is recommended for QPS status with the qualifications of ‘for production
purposes only’ and ‘absence of cytotoxic activity’.
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Glossary
Anamorph name Valid name of a fungus based on the asexual reproductive state
(morphologically)
Antimicrobial compounds Antibiotics, bacteriocins and/or small peptides with antimicrobial
activity
Basonym name the earliest validly published name of a taxon
Synonymous name/Homotypic
synonym
have the same type (specimen) and the same taxonomic rank.





BIOHAZ EFSA Panel on Biological Hazards
ELS extensive Literature Search
FIP EFSA Food ingredients and packaging Unit
FSTA Food Science Technology Abstracts
GMM genetically modified microorganism
MALDI-TOF matrix-assisted laser desorption/ionisation (MALDI), time-of-flight (TOF)
QPS qualified presumption of safety
ToR Terms of Reference
TU taxonomic unit
WG Working Group
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Appendix A – Search strategy followed for the (re)assessment of the
suitability of TUs notified to EFSA not present in the current QPS list for
their inclusion in the updated list (reply to ToR 3)
A.1. Bacillus circulans
A search for the body of knowledge on B. circulans was done in the databases mentioned above,
considering all years available in these databases, using a range of search terms in relation to food
and feed, combined with ‘Bacillus circulans’. Seventy-one were screened.
Strings:
(food* OR feed* OR beverage* OR meat OR fish OR dairy OR milk OR vegetable* OR fruit* OR
cereal* OR wheat OR barley OR rice OR rey OR grain* OR legum* OR bean* OR probiotic* OR
fermented OR dish* OR condiment* OR pure* OR meal* OR enzyme* OR chitinas* OR polysacch*)
AND Bacillus circulans
71 hits -last 5 years
toxi* OR disease* OR infection* OR virulence OR abortion* OR mastitis* OR bacteremi* OR
poisoning OR hepatitis OR necrosis OR necrotizing OR pneumonia OR endophthalmitis OR gangrene
OR endocarditis OR ‘urinary tract’ OR meningitis OR encephalopathy OR parodontitis OR liver OR
hepatotoxi* OR abscess OR death OR mortal* Or morbid*OR sepsis OR colitis OR Pathogen* OR
patholog* AND Bacillus circulans
22 hits -last 5 years
A.2. Methylorubrum extorquens
Methylorubrum/Methylobacterium extorquens; Pub Med: 577 hits,
With review: 26 hits
With safety 1 hit
With case report: 1 hit
With antimicrobial resistance: 8 papers
A.3. Mycobacterium aurum
“Mycobacterium aurum” AND infect* OR diseas* OR intox* OR toxin*; PubMed: 42 hits
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Appendix B – Protocol for Extensive literature search (ELS), relevance
screening and article evaluation for the maintenance and update of list of
QPS-recommended biological agents (reply to ToR 2)
The protocol for extensive literature search (ELS) used in the context of the EFSA mandate on the
list of QPS-recommended biological agents intentionally added to the food or feed (EFSA-Q-2020-
00078) is available on the EFSA Knowledge Junction community on Zenodo, at: https://doi.org/
10.5281/zenodo.4428668
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Appendix C – Search strategies for the maintenance and update of list of
QPS-recommended biological agents (reply to ToR 2)
The search strategies for each taxonomic unit (TU), i.e. the string for each TU and the search
outcome, are available on the EFSA Knowledge Junction community on Zenodo at: https://doi.org/
10.5281/zenodo.4428691
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Appendix D – References selected from the ELS exercise with potential
safety concerns for searches January–June 2020 (reply to ToR 2) and
January 2019 to June 2020 for protists/algae
Gram-Positive Non-Sporulating Bacteria
Bifidobacterium
Sirichoat A, Belen Florez A, Vazquez L, Buppasiri P, Panya M, Lulitanond V and Mayo B, 2020. Antibiotic
susceptibility profiles of lactic acid bacteria from the human vagina and genetic basis of acquired
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case report in France and literature review. IDCases, 21, e00811.
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associated with probiotic therapy in an extremely preterm infant: Pathogenesis and a review for
clinicians. Journal of Microbiology, Immunology, and Infection.
Ozer M, Goksu SY, Shahverdiani A and Mustafa M, 2020. Lactobacillus acidophilus-induced endocarditis
and associated splenic abscess. Case Reports in Infectious Diseases, 2020.
Sendil S, Shrimanker I, Mansoora Q, Goldman J and Nookala VK, 2020. Lactobacillus rhamnosus
Bacteremia in an Immunocompromised Renal Transplant Patient. Cureus, 12.
Tavernese A, Stelitano M, Mauceri A, Mollace R, Uccello G, Romeo F and Cammalleri V, 2020.
Progression of Lactobacillus plantarum prosthetic valve endocarditis followed by transesophageal
echocardiogram. International Journal of Infectious Diseases: IJID : official publication of the
International Society for Infectious Diseases, 97, 160–161.
Lactococcus lactis
Daneshamouz S, Haghi F and Zeighami H, 2020. Detection and identification of bacterial pathogens in
rainbow trout (Oncorhynchus mykiss) samples from fish farms in Iran. Thalassas, 36, 133–141.
Smith JCS, Moroni P, Santisteban CG, Rauch BJ, Ospina PA and Nydam DV, 2020. Distribution of
Lactococcus spp. in New York State dairy farms and the association of somatic cell count resolution
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Gram-Positive Spore-forming Bacteria
Bacilli
Bog ES, Erturk O and Yaman M, 2020. Pathogenicity of aerobic bacteria isolated from honeybees (Apis
mellifera) in Ordu Province. Turkish Journal of Veterinary & Animal Sciences, 44, 714–719.
Farhan MG, Abd El-Hamid MI and Hassan MN, 2020. Propidium monoazide conventional PCR and DNA
sequencing: detection of negative culture bacterial pathogens causing subclinical mastitis. Journal
of Applied Microbiology, 128, 1595–1605.
Mohkam M, Nezafat N, Berenjian A, Zamani M, Dabbagh F, Bigharaz R and Ghasemi Y, 2020.












Aboualigalehdari E, Tahmasebi Birgani M, Fatahinia M and Hosseinzadeh M, 2020. Oral Colonization by
Candida Species and Associated Factors among HIV-infected Patients in Ahvaz, Southwest Iran.
Epidemiology and health, e2020033.
Bhaskaran R, Valsan C and Sathiavathy KA, 2020. Molecular speciation and antifungal susceptibility
profile of Candida Species in a Tertiary Care Centre in Central Kerala. Journal of Evolution of Medical
and Dental Sciences-Jemds, 9, 357–362.
Davies E, Shipp A, Hawkes R and Wynn RF, 2020. Successful management of hepatosplenic infection
due to saccharomyces cerevisiae in a child with acute lymphoblastic leukemia. Journal of Pediatric
Hematology Oncology, 42, E117-E120.
Esteves CV, Freitas RS, e Campos WG, Shimabukuro N, Thomaz DY, Cordas T, Benard G, Witzel AL and
Lemos CA, 2020. Oral yeast colonization in patients with eating disorders: commensal acquisition or
due to purgative habits? Revista Do Instituto De Medicina Tropical De Sao Paulo, 62.
Fernanda Landaburu M, Lopez Daneri GA, Relloso S, Jorge Zarlenga L, Alejandra Vinante M and Teresa
Mujica M, 2020. Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in
an elderly patient. Revista Argentina De Microbiologia, 52, 27–30.
Gkentzi D, Marangos M, Karatza A, Spiliopoulou A, Varvarigou A and Dimitriou G, 2020. Saccharomyces
cerevisiae fungaemia in an immunocompetent toddler. Journal of Paediatrics and Child Health, 56,
182.
Kord M, Salehi M, Khodavaisy S, Hashemi SJ, Ghazvini RD, Rezaei S, Maleki A, Elmimoghaddam A,
Alijani N, Abdollahi A, Doomanlou M, Ahmadikia K, Rashidi N, Pan W, Boekhout T and Arastehfar A,
2020. Epidemiology of yeast species causing bloodstream infection in Tehran, Iran (2015-2017);
superiority of 21-plex PCR over the Vitek 2 system for yeast identification. Journal of Medical
Microbiology, 69, 712–720.
Mirhendi H, Charsizadeh A, Eshaghi H, Nikmanesh B and Arendrup MC, 2020. Species distribution and
antifungal susceptibility profile of Candida isolates from blood and other normally sterile foci from
pediatric ICU patients in Tehran, Iran. Medical Mycology, 58, 201–206.
Pote ST, Sonawane MS, Rahi P, Shah SR, Shouche YS, Patole MS, Thakar MR and Sharma R, 2020.
Distribution of pathogenic yeasts in different clinical samples: their identification, antifungal
susceptibility pattern, and cell invasion assays. Infection and Drug Resistance, 13, 1133–1145.
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Song KY, Park C, Byun J-H, Chun H-S, Choi J-H, Han EH, Lee SO, Jeong Y, Kim YJ and Kim S-H, 2020.
Fungal arthritis with adjacent osteomyelitis caused by Candida pelliculosa: a case report. Bmc
Infectious Diseases, 20, 438.
Protists/algae
For protists/algae, the time period searched was from January 2019 to June 2020.
None
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Appendix E – The 2020 updated list of QPS Status recommended biological
agents in support of EFSA risk assessments
The list of QPS status recommended biological agents (EFSA BIOHAZ Panel, 2020a) is being
maintained in accordance with the mandate of the BIOHAZ Panel (2020–2022), extended for the
following years. Possible additions to this list are included around every 6 months, with the last
Panel Statement 12 adopted in June 2020 (EFSA BIOHAZ Panel, 2020b). These additions are published as
updates to the Scientific Opinion (EFSA BIOHAZ Panel, 2020a); the updated QPS list is available at
https://doi.org//10.2903/j.efsa.2021.6377 and, as of January 2018, also as supporting information linked
to every Panel Statement available on the Knowledge Junction at https://doi.org/10.5281/zenodo.
4428353.
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Bacillus amyloliquefaciens CECT 5490 Feed additives Ecobiol, Ecobiol 500, Ecobiol
Plus (Bacillus amyloliquefaciens
CECT 5940)
EFSA-Q-2020-00452 Y No (already QPS)
Bacillus amyloliquefaciens TOA5001 Feed additives Zootechnical
additives
Gut microbiota stabiliser EFSA-Q-2020-00496 Y No (already QPS)










Y No (already QPS)
Bacillus subtilis TO-A Feed additives Zootechnical
additives
Viable spores of Bacillus
subtilis TO-A, Enterococcus
faecium T-110, Clostridium
butyricum TO-A used as gut
microbiota stabilisers for
chickens for fattening,
chickens reared for laying/
breeding,
EFSA-Q-2020-00556 Y No (already QPS)
Bacillus subtilis CGMCC 13326 Feed additives Nutritional
additives
Production of Vitamin B2 EFSA-Q-2020-00637 Y No (already QPS)
Bacillus subtilis ROM Food enzymes,
food additives
and flavourings
Production of glucan 1,4- -
maltohydrolase
EFSA-Q-2020-00583 Y No (already QPS)
Bifidobacterium bifidum Novel foods Production of enzyme used in
production process of
Galacto-oligosaccharide
EFSA-Q-2020-00466 Y No (already QPS)
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Clostridium butyricum TO-A Feed additives Zootechnical
additives
Viable spores of Bacillus
subtilis TO-A, Enterococcus
faecium T-110, Clostridium
butyricum TO-A used as gut
microbiota stabilisers for
chickens for fattening,
chickens reared for laying/
breeding,







Production of amino acid,
their salts and analogues
EFSA-Q-2020-00326
(FAD-2020-0024)

















L-valine for all animal species EFSA-Q-2020-00375
(FAD-2020-0033)







Used for the production of L-
glutamic acid and
monosodium glutamate
EFSA-Q-2020-00502 Y No (already QPS)
Enterococcus faecium T-110 Feed additives Zootechnical
additives
Viable spores of Bacillus
subtilis TO-A, Enterococcus
faecium T-110, Clostridium
butyricum TO-A used as gut
microbiota stabilisers for
chickens for fattening,
chickens reared for laying/
breeding,
EFSA-Q-2020-00556 N No (excluded)




Production of amino acid,










EFSA-Q-2020-00499 N No (excluded)
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monohydrate to permit use as
nutritional and sensory
additive
EFSA-Q-2020-00604 N No (excluded)
Lactobacillus plantarum DSM26571 Feed additives Technological
additives
Technical additive: silage EFSA-Q-2020-00279
(FAD-2019-0091)
Y No (already QPS)
Lactobacillus plantarum DSM 21762 Feed additives Technological
additives
Lactobacillus plantarum DSM
21762 is added to the forage,
used for ensiling process. The
obtained silage can be fed to
all animal species/categories.








extorquens KB203 for use in
feed
EFSA-Q-2020-00397 N Yes











Aspergillus flavus MUCL54911 Plant protection
products
Plant protection product EFSA-Q-2020-00506 N No (excluded)
Aspergillus oryzae Novel foods Modification of the conditions
of use of an already
authorised novel food
EFSA-Q-2020-00466 N No (excluded)
Aureobasidium pullulans SM-2001 Novel foods Novel Food Production of beta-glucan EFSA-Q-2020-00264
(NF 2018/0741)
N No (excluded)
Aureobasidium pullulans Food enzymes,
food additives
and flavourings
Production of an extra cellular
polysaccharide by
Aureobasidium pullulans
EFSA Q 2020-00517 N No (excluded)
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EFSA-Q-2020-00476 N No (excluded)
Trichoderma harzianum T78 - The
strain T78 is a
natural and








Plant protection product EFSA-Q-2020-00616 N No (excluded)
Yeasts






EFSA Q 2020-00520 Y No (already QPS)




Y No (already QPS)
Saccharomyces cerevisiae CNCMI-3060 Feed additives Nutritional
additives
Organic form of Selenium
produced by Saccharomyces
cerevisiae CNCM I-3060.
EFSA-Q-2020-00495 Y No (already QPS)
Saccharomyces cerevisiae M17906 Food enzymes,
food additives
and flavourings
Production of the food
enzyme maltogenic a-amylase







BCCM/MUCL 39885 used as
gut microbiota stabilisers in all
pigs (other than sows and
weaned piglets) and all minor
porcine species
EFSA-Q-2020-00600 Y No (already QPS)
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BCCM/MUCL 39885 used as
gut microbiota stabilisers in
pets (cats and dogs) not used
for food-producing animals
EFSA-Q-2020-00603 Y No (already QPS)
Yarrowia lipolytica A-101 Novel foods Novel Food Production of inactivated
yeast biomass as novel food
EFSA-Q-2020-00491 Y No (already QPS)
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